An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension
about
Molecular pathogenesis of pulmonary arterial hypertensionPulmonary Hypertension and Indicators of Right Ventricular FunctionRedox biology in pulmonary arterial hypertension (2013 Grover Conference Series)Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and CancersImmune and inflammatory mechanisms in pulmonary arterial hypertensionMolecular mechanisms of pulmonary arterial remodelingDNA Damage and Pulmonary HypertensionHypoxia-inducible factors in physiology and medicineMetabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial HypertensionThe emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)Metabolic Functions of the Lung, Disorders and Associated PathologiesThe emerging role of AMPK in the regulation of breathing and oxygen supplyEmerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertensionMitochondrial metabolism and the control of vascular smooth muscle cell proliferationNew Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in HumansThe nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targetedPGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertensionHIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanismDynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertensionThe right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Reciprocal backcross mice confirm major loci linked to hyperoxic acute lung injury survival time.Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation.Emerging Metabolic Therapies in Pulmonary Arterial Hypertension.Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.Hypoxia-induced pulmonary hypertension in type 2 diabetic mice.Expression of hypoxia-inducible factor-1α, endothelin-1 and adrenomedullin in newborn rats with hypoxia-induced pulmonary hypertensionGenomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.The cancer theory of pulmonary arterial hypertension.Desferroxamine infusion increases cerebral blood flow: a potential association with hypoxia-inducible factor-1.Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesCoenzyme Q supplementation in pulmonary arterial hypertension.Schistosomiasis-induced experimental pulmonary hypertension: role of interleukin-13 signaling.Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertensionChronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.NOX4 mediates BMP4-induced upregulation of TRPC1 and 6 protein expressions in distal pulmonary arterial smooth muscle cellsValidation of high-resolution echocardiography and magnetic resonance imaging vs. high-fidelity catheterization in experimental pulmonary hypertension.
P2860
Q24634317-D5F41F33-4352-4335-ACBC-0FA92EE75035Q26744781-472D240D-C0D4-4227-BEE5-F203F69BF154Q26772286-45BE25F8-7C7C-4007-A5F0-AD3D23EE983DQ26822845-A6533E0F-728B-467C-88F8-1F24209DDACBQ26851508-92BF7BD2-27DF-4D32-87D5-9BE2920B4872Q26991806-30CCAFEE-959B-447C-895A-23CA5724A95DQ27005594-017F877A-329B-4ED9-BA41-FE296FE520EBQ27013770-CC0014D0-AE65-464A-B11D-916E0BAD1495Q27024293-150B2E2A-5810-430B-B7C3-3801FCEE6E64Q27026643-B1358851-B5CA-4382-A809-E0DB78FC1E68Q27687091-E9488645-0347-4252-AD70-41332FBA10B7Q28067063-9B62524E-F177-443E-98D4-06A0F027A42BQ28069443-3500E235-EDA3-4DF8-A6E1-874A5D0E98EEQ28072037-729597C6-917D-4702-9AB7-3AD229D75BE9Q28072485-DC32D422-FFD9-49D5-819D-53D68ED900BFQ28083183-B137A7DE-9FE7-4D22-956A-F5FA7E0CB48FQ28083322-4ECE4126-51D2-4ED8-93CB-89BE8FCDB50DQ28553362-AF573B26-6042-4578-8BBC-B9DC3D128D3DQ28567772-7687BC6D-AEF9-46B2-A44F-A37FA2D5571CQ28578858-65C13B0A-F2E4-4546-A3E0-1397802C22FCQ28583933-EBC498CC-7818-47A7-9189-D030AD18FA71Q30531765-D644778A-6333-476F-93F3-F100043B13BFQ30585014-705818B1-E28B-40BC-BA14-AED3169FAA3CQ33439378-FFB5592F-E8A5-4D7E-A932-B5470C5545ECQ33556948-9A7EE2D1-8518-440B-97CE-907C26F3020BQ33608219-230C7EB4-60FA-4B66-A2B9-85BB22DDF384Q33703652-642002C1-16D2-4366-91A3-C45667A84AB1Q33738536-241523D9-AFDA-4487-8AE9-6D20F8E43140Q33769701-D18D5CF6-F429-4425-AFC9-C7BED3EAD20DQ33784417-53BF048C-B526-419B-A6D4-781B48E205ECQ33788493-4290F794-C84A-4C13-B50E-D968BCF20735Q33789109-846A637B-6473-4C82-8407-9D3CE7C68855Q33806068-2E802546-08D9-4AAB-B921-965827CE43BFQ33849207-4DC74404-62D9-4420-8308-44162DF9B462Q34085977-6580EFC6-0AA8-4DF9-B291-FD3293801E7AQ34087045-C994FB80-AF00-4F9D-B41A-983DC822733EQ34127884-F5122E39-6118-4686-99C3-AA18E2ED5DA0Q34131753-9228B180-F6C0-4B8C-B354-50A3B4DC13E4Q34156155-D9699360-2008-4800-B1F2-A8647EA7FC46Q34180746-78752EB8-822C-4229-8C93-AF39EB5BDE69
P2860
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension
description
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juni 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/06/06)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/06/06)
@nl
наукова стаття, опублікована в червні 2006
@uk
مقالة علمية (نشرت في 6-6-2006)
@ar
name
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@ast
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@en
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@nl
type
label
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@ast
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@en
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@nl
prefLabel
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@ast
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@en
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@nl
P2093
P921
P3181
P1433
P1476
An abnormal mitochondrial-hypo ...... ulmonary arterial hypertension
@en
P2093
Alois Haromy
Bernard Thébaud
Christopher J. Porter
E. Kenneth Weir
Evangelos D. Michelakis
Gwyneth Harry
M. Sean McMurtry
Miguel A. Andrade-Navarro
Rohit Moudgil
Sandra Bonnet
P304
P3181
P356
10.1161/CIRCULATIONAHA.105.609008
P407
P577
2006-06-06T00:00:00Z